From #MeToo to Black Lives Matter, as a society we have been discussing the relationship between representation and equality more than ever over the last few years.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh